Directory
>
Aimee Rieger
Aimee Rieger
Vice President, Clinical Operations | Arcus Biosciences
Baltimore, Maryland, United States
Aimee Rieger
Summary
Aimee Rieger is a seasoned professional in the biopharmaceutical industry, currently serving as the Vice President and Head of Clinical Operations at Arcus Biosciences. With over 15 years of experience, she has held various leadership roles, showcasing her expertise in clinical operations, drug development, and clinical research. Aimee's career trajectory reflects a consistent upward movement within the same organization, highlighting her loyalty and deep understanding of the industry. She has been instrumental in overseeing clinical trials from Phase I through Phase III, focusing on oncology and infectious diseases. Aimee is known for her strategic approach to clinical operations, ensuring compliance with regulatory standards while driving innovation. Her academic background from Illinois Wesleyan University complements her extensive practical experience. Aimee is passionate about improving patient outcomes through effective clinical practices and is actively involved in mentoring emerging leaders in her field.
Aimee Rieger
Work Experience
Vice President, Clinical Operations at
Arcus Biosciences
February 2022 - Present
Sr. Director, Head of Clinical Operations at
Arcus Biosciences
January 2022 - February 2022
Senior Director, Clinical Operations at
Arcus Biosciences
July 2021 - January 2022
Director, Clinical Operations at
Arcus Biosciences
January 2019 - July 2021
Associate Director Clinical Operations at
Arcus Biosciences
May 2017 - January 2019
Associate Director at
MedImmune
June 2016 - May 2017
Sr. CPM at
MedImmune
June 2014 - June 2016
CPM at
MedImmune
May 2012 - June 2014
ACPM at
MedImmune
June 2010 - May 2012
Sr. CRA at
MedImmune
August 2009 - June 2010
CRA I & II at
MedImmune
September 2005 - October 2008
Aimee Rieger
Education
Frequently Asked Questions about Aimee Rieger
What is Aimee Rieger email address?
Aimee Rieger's primary email address is *******@arcusbio.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Aimee Rieger work for?
Aimee Rieger is a Vice President, Clinical Operations at Arcus Biosciences, a company specializing in Commercial physical research.
Where Aimee Rieger graduated from?
Aimee Rieger holds a degree in from Illinois Wesleyan University.
How can I directly contact Aimee Rieger?
To contact Aimee Rieger directly, you can use the email address *******@arcusbio.com. Complete contact information is available upon registration with Muraena.
Who is Aimee Rieger?
Aimee Rieger is a seasoned professional in the biopharmaceutical industry, currently serving as the Vice President and Head of Clinical Operations at Arcus Biosciences. With over 15 years of experience, she has held various leadership roles, showcasing her expertise in clinical operations, drug development, and clinical research. Aimee's career trajectory reflects a consistent upward movement within the same organization, highlighting her loyalty and deep understanding of the industry. She has been instrumental in overseeing clinical trials from Phase I through Phase III, focusing on oncology and infectious diseases. Aimee is known for her strategic approach to clinical operations, ensuring compliance with regulatory standards while driving innovation. Her academic background from Illinois Wesleyan University complements her extensive practical experience. Aimee is passionate about improving patient outcomes through effective clinical practices and is actively involved in mentoring emerging leaders in her field.
Aimee`s contact details
*******@arcusbio.com
Colleagues
Vice President, Product Strategy Team Development Lead
Executive Director, Portfolio Strategy & Market Planning
Executive Director, Clinical Development
Executive Director, Marketing and Portfolio Strategy
Chief Accounting Officer (CAO)
Executive Director of Clinical Data Management
Vice President, Intellectual Property
Senior Vice President
Executive Director, Head of FP&A
CEO